William Ackman
Bill Ackman runs hedge fund Pershing Square Capital, which he started in 2003 following the dissolution of Gotham Partners.
Ackman is a value investor with an activist bent. Activist investors agitate management for changes. He owns large positions in Target (NYSE: TGT) and Borders (NYSE: BGP). He has also been involved in activist situations at Wendy's (NYSE: WEN) and McDonald's (NYSE: MCD).
Ackman proved his acumen as a short seller in 2007/2008 as short positions he held in MBIA (NYSE: MBI) and Ambac (NYSE: ABK) proved to be big winners due to the credit crunch.
In July 2008, Ackman said he was short the common stock of Fannie Mae (NYSE: FNM) and Freddie Mac (NYSE: FRE). Ackman also laid out a plan to reorganize the GSEs, which would wipe out the common shareholders.
View Older Stories View More Recent Stories
-
ADP (ADP) PT Raised to $105 at BMO Capital on 4Q Report; 'Ackman Bounce Negates Weak Trends'
-
ADP (ADP) PT Raised to $108 at Stifel on 4Q Report; 'Stock Action & Reports of Activist More Perplexing'
-
Baird Comments On Pershing Square Position in ADP (ADP)
-
UPDATE: Bill Ackman is Said to Build Stake in ADP (ADP) - Bloomberg
-
Bill Ackman Tweets on Chipotle Mexican Grill (CMG) in First Ever Tweet
-
Pershing Square Holdings, Ltd. Announces Second Quarter 2017 Investor Call
-
Chatty billionaire Ackman grabs bigger megaphone with Twitter account
-
Pershing Square's Bill Ackman Joins Twitter using @BillAckman1
-
Blackstone (BX) Formed Consortium to Buy Half of Platform Specialty Products (PAH) - NYP
-
Billionaire investor Paulson joins Valeant board, shares jump
-
Bill Ackman can't appear Allergan (AGN) investors' class-action status - Bloomberg
-
Hedge fund managers can show off with better returns in May
-
WPP AGM Trading Update
-
Ackman Issues Statement on Herbalife (HLF) - CNBC
-
Herbalife says second-quarter sales to fall more than expected
-
Hedge fund managers can show off with better returns in May
-
Buffalo Wild Wings CEO to retire as activist Marcato wins board seats
-
Brown-Forman (BF.B) Gains Again with Chatter Abound
-
Humbled by Valeant, Ackman goes back to basics
-
Washington dreams on hold, Scaramucci revels in Las Vegas glow
-
Icahn takes new 19.8 million share stake in Conduent in first quarter
-
ValueAct's Ubben taps Morfit for CIO post in succession plan
-
Ackman has a winner that is up 30 percent but will not name names
-
R Baby Foundation's Seventh Annual New York Tennis Tournament Raises $250,000
-
Drugmaker Valeant raises profit forecast; shares spike
-
Property, merger bets dominate picks at Sohn conference
-
Ackman pitches Howard Hughes, citing management and real estate locations
-
Pershing Square Bill Ackman Discusses Howard Hughes (HHC) Again at Sohn
-
Six New York City Scientists Win Pershing Square Sohn Prize for Young Investigators in Cancer Research
-
Herbalife CEO talks about obesity, vindication at Milken Conference
-
WPP Quarterly Trading Update
-
Pershing Square Holdings, Ltd. Announces First Quarter 2017 Investor Call
-
Sohn Investment Idea Contest Sponsored by GLG Is Accepting Submissions in Advance of 22nd Annual Sohn Investment Conference
-
Mondelez lays groundwork to replace its CEO: WSJ
-
Chipotle shareholders pull vote to split CEO, chairman jobs
-
9th Annual SALT Conference to Take Place May 16-19th, 2017 in Las Vegas
-
Ackman apologizes for Valeant losses, calls bet a mistake
-
Fannie, Freddie investors seek rehearing of U.S. case on profit seizure
-
Ackman's Pershing Square Holdings seeks London listing
-
Hedge fund manager Eric Mindich shuts down Eton Park
-
Senate panel presses SEC nominee Clayton on conflicts
-
NBA's Chris Paul, other celebrity athletes, invest for a cause
-
Chipotle says one-third of directors will not run again
-
ValueAct boosts Valeant stake after Pershing exits
-
ValueAct Buys 3M Valeant Pharma (VRX) Shares
-
Valeant shares fall as Ackman exit highlights company's challenges
-
Ackman's Pershing Square Confirms Liquidating Valeant Pharma (VRX) Stake
-
LPC: Valeant refinancing on track despite Ackman stock sale
-
Valeant (VRX) call put ratio 1 to 1 after Ackman’s Pershing Square liquidates his entire stake
-
Bill Ackman tells CNBC 'I should have sold Valeant Pharma (VRX) sooner'

